In the AD brain, alterations in the PI3K-Akt pathway primarily manifest as decreased phosphorylation or total levels of the components in the insulin-PI3K-Akt signaling cascade (Steen et al., 2005; Liu et al., 2011). This evidence concerns the gene AKT1 and Alzheimer disease.